Leap Investments’s Boston Scientific BSX Stock Holding History

Leap Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$383K	Buy	+10,900	New	+$393K	0.25%	147

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Leap Investments's BSX Position: Q2 2020 in Review

Leap Investments opened a new position in Boston Scientific (BSX) in Q2 2020: 10,900 shares worth $383K. The stake represents 0.25% of the portfolio and ranks #147 among its holdings.

840 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

Leap Investments held 10,900 shares of Boston Scientific worth $383K as of Q2 2020.
Boston Scientific was a new Leap Investments position in Q2 2020.
Boston Scientific made up 0.25% of Leap Investments's portfolio in Q2 2020, its #147 holding.
840 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.